10 Best Biotech Stocks Under $10
In this article, we will take a look at the 10 best Biotech stocks under $10.
Cytomx Therapeutics Inc. (CTMX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 6,595,801 | $10,553,282 | 0.44% | |
| 2. | Tang Capital Management Kevin C. Tang | 3,510,445 | $5,616,712 | +1% | 0.81% |
| 3. | Rubric Capital Management David Rosen | 2,406,449 | $3,850,318 | 0.16% | |
| 4. | Laurion Capital Management Benjamin A. Smith | 1,270,900 | $2,033,440 | 0% | |
| 5. | Platinum Asset Management Kerr Neilson | 635,798 | $1,017,277 | -49% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.33 | 9,000 | Officer | 9,979 | 2019-03-04 | Filing | |
| $12.00 | 3,000 | Officer | 3,000 | 2015-10-14 | Filing | |
| $12.00 | 5,000 | Officer | 5,000 | 2015-10-14 | Filing | |
| $12.00 | 5,000 | Director | 5,000 | 2015-10-14 | Filing | |
| $12.00 | 10,000 | Director | 147,791 | 2015-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.98 | 516 | 37,772 | 2023-03-16 | Filing | ||
| $1.98 | 1,748 | 38,224 | 2023-03-16 | Filing | ||
| $1.88 | 7,121 | 388,821 | 2023-03-16 | Filing | ||
| $1.98 | 2,037 | 71,095 | 2023-03-16 | Filing | ||
| $1.98 | 1,477 | 69,248 | 2023-03-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 4,585,721 | $7,337,154 | 0% | |
| 2. | 1,300,001 | $2,080,002 | 0% | |
| 3. | 740,724 | $1,185,158 | 0% | |
| 4. | 716,646 | $1,146,634 | 0% | |
| 5. | 661,892 | $1,059,028 | 0% |
News See All
10 Small-Cap Stocks to Buy According to Billionaire Steve Cohen
In this article, we discuss the 10 small-cap stocks to buy according to billionaire Steve Cohen.
Is CTMX A Good Stock To Buy According To Hedge Funds?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money managers and analyze their...
Hedge Funds Are Bullish On CytomX Therapeutics, Inc. (CTMX)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Did Hedge Funds Make The Right Call On CytomX Therapeutics, Inc. (CTMX) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Hedge Funds Standing By CytomX Therapeutics, Inc. (CTMX)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Hedge Funds Have Never Been More Bullish On CytomX Therapeutics, Inc. (CTMX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
CytomX Therapeutics, Inc. (CTMX) Is Burning These Hedge Funds
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.
Here's What Hedge Funds Think About CytomX Therapeutics, Inc. (CTMX)
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.
Were Hedge Funds Right About Dumping CytomX Therapeutics, Inc. (CTMX)?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Billionaire Hedge Funds
